166 related articles for article (PubMed ID: 36882608)
21. Genetic variants in one-carbon metabolism genes and breast cancer risk in European American and African American women.
Gong Z; Yao S; Zirpoli G; David Cheng TY; Roberts M; Khoury T; Ciupak G; Davis W; Pawlish K; Jandorf L; Bovbjerg DH; Bandera EV; Ambrosone CB
Int J Cancer; 2015 Aug; 137(3):666-77. PubMed ID: 25598430
[TBL] [Abstract][Full Text] [Related]
22. Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS).
Gong Z; Quan L; Yao S; Zirpoli G; Bandera EV; Roberts M; Coignet JG; Cabasag C; Sucheston L; Hwang H; Ciupak G; Davis W; Pawlish K; Jandorf L; Bovbjerg DH; Ambrosone CB; Hong CC
PLoS One; 2013; 8(8):e72619. PubMed ID: 23991131
[TBL] [Abstract][Full Text] [Related]
23. Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers.
Min Z; Mi Y; Lv Z; Sun Y; Tang B; Wu H; Zhang Z; Pan H; Zhang Y; Lu C; Zuo L; Zhang L
Dis Markers; 2022; 2022():1720851. PubMed ID: 35082928
[TBL] [Abstract][Full Text] [Related]
24. Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival.
Pande M; Bondy ML; Do KA; Sahin AA; Ying J; Mills GB; Thompson PA; Brewster AM
Breast Cancer Res Treat; 2014 Sep; 147(2):381-7. PubMed ID: 25108739
[TBL] [Abstract][Full Text] [Related]
25. Lifetime recreational exercise activity and breast cancer risk among black women and white women.
Bernstein L; Patel AV; Ursin G; Sullivan-Halley J; Press MF; Deapen D; Berlin JA; Daling JR; McDonald JA; Norman SA; Malone KE; Strom BL; Liff J; Folger SG; Simon MS; Burkman RT; Marchbanks PA; Weiss LK; Spirtas R
J Natl Cancer Inst; 2005 Nov; 97(22):1671-9. PubMed ID: 16288120
[TBL] [Abstract][Full Text] [Related]
26. Functional promoter rs2295080 T>G variant in MTOR gene is associated with risk of colorectal cancer in a Chinese population.
Xu M; Gao Y; Yu T; Wang J; Cheng L; Cheng L; Cheng D; Zhu B
Biomed Pharmacother; 2015 Mar; 70():28-32. PubMed ID: 25776475
[TBL] [Abstract][Full Text] [Related]
27. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.
Yu JC; Hsu HM; Chen ST; Hsu GC; Huang CS; Hou MF; Fu YP; Cheng TC; Wu PE; Shen CY
J Biomed Sci; 2006 May; 13(3):419-32. PubMed ID: 16502042
[TBL] [Abstract][Full Text] [Related]
29. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study.
Ambrosone CB; Zirpoli G; Ruszczyk M; Shankar J; Hong CC; McIlwain D; Roberts M; Yao S; McCann SE; Ciupak G; Hwang H; Khoury T; Jandorf L; Bovbjerg DH; Pawlish K; Bandera EV
Cancer Causes Control; 2014 Feb; 25(2):259-65. PubMed ID: 24249438
[TBL] [Abstract][Full Text] [Related]
30. Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium.
Hong CC; Sucheston-Campbell LE; Liu S; Hu Q; Yao S; Lunetta KL; Haddad SA; Ruiz-Narváez EA; Bensen JT; Cheng TD; Bandera EV; Rosenberg LA; Haiman CA; Lee K; Evans SS; Abrams SI; Repasky EA; Olshan AF; Palmer JR; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):321-330. PubMed ID: 29339359
[No Abstract] [Full Text] [Related]
31. Associations of dietary folate, Vitamins B6 and B12 and methionine intake with risk of breast cancer among African American and European American women.
Gong Z; Ambrosone CB; McCann SE; Zirpoli G; Chandran U; Hong CC; Bovbjerg DH; Jandorf L; Ciupak G; Pawlish K; Lu Q; Hwang H; Khoury T; Wiam B; Bandera EV
Int J Cancer; 2014 Mar; 134(6):1422-35. PubMed ID: 23996837
[TBL] [Abstract][Full Text] [Related]
32. Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry.
Wang S; Huo D; Ogundiran TO; Ojengbede O; Zheng W; Nathanson KL; Nemesure B; Ambs S; Olopade OI; Zheng Y
Mol Carcinog; 2018 Oct; 57(10):1311-1318. PubMed ID: 29873413
[TBL] [Abstract][Full Text] [Related]
33. A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population.
Xu M; Tao G; Kang M; Gao Y; Zhu H; Gong W; Wang M; Wu D; Zhang Z; Zhao Q
PLoS One; 2013; 8(3):e60080. PubMed ID: 23555892
[TBL] [Abstract][Full Text] [Related]
34. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Lei J; Rudolph A; Moysich KB; Rafiq S; Behrens S; Goode EL; Pharoah PP; Seibold P; Fasching PA; Andrulis IL; Kristensen VN; Couch FJ; Hamann U; Hooning MJ; Nevanlinna H; Eilber U; Bolla MK; Dennis J; Wang Q; Lindblom A; Mannermaa A; Lambrechts D; García-Closas M; Hall P; Chenevix-Trench G; Shah M; Luben R; Haeberle L; Ekici AB; Beckmann MW; Knight JA; Glendon G; Tchatchou S; Alnæs GI; Borresen-Dale AL; Nord S; Olson JE; Hallberg E; Vachon C; Torres D; Ulmer HU; Rüdiger T; Jager A; van Deurzen CH; Tilanus-Linthorst MM; Muranen TA; Aittomäki K; Blomqvist C; Margolin S; Kosma VM; Hartikainen JM; Kataja V; Hatse S; Wildiers H; Smeets A; Figueroa J; Chanock SJ; Lissowska J; Li J; Humphreys K; Phillips KA; ; Linn S; Cornelissen S; van den Broek SA; Kang D; Choi JY; Park SK; Yoo KY; Hsiung CN; Wu PE; Hou MF; Shen CY; Teo SH; Taib NA; Yip CH; Ho GF; Matsuo K; Ito H; Iwata H; Tajima K; Dunning AM; Benitez J; Czene K; Sucheston LE; Maishman T; Tapper WJ; Eccles D; Easton DF; Schmidt MK; Chang-Claude J
Breast Cancer Res; 2015 Feb; 17(1):18. PubMed ID: 25849327
[TBL] [Abstract][Full Text] [Related]
35. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
Le Rhun E; Bertrand N; Dumont A; Tresch E; Le Deley MC; Mailliez A; Preusser M; Weller M; Revillion F; Bonneterre J
Eur J Cancer; 2017 Dec; 87():189-198. PubMed ID: 29103666
[TBL] [Abstract][Full Text] [Related]
36. Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women.
Barber LE; Zirpoli GR; Cozier YC; Rosenberg L; Petrick JL; Bertrand KA; Palmer JR
Breast Cancer Res; 2021 Nov; 23(1):108. PubMed ID: 34809694
[TBL] [Abstract][Full Text] [Related]
37. Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.
Shu X; Lin J; Wood CG; Tannir NM; Wu X
J Natl Cancer Inst; 2013 Mar; 105(6):424-32. PubMed ID: 23378641
[TBL] [Abstract][Full Text] [Related]
38. Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women.
Gabriel CA; Mitra N; Demichele A; Rebbeck T
Breast Cancer Res Treat; 2013 Jun; 139(3):833-43. PubMed ID: 23764995
[TBL] [Abstract][Full Text] [Related]
39. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
[TBL] [Abstract][Full Text] [Related]
40. Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer.
Lin J; Wang J; Greisinger AJ; Grossman HB; Forman MR; Dinney CP; Hawk ET; Wu X
Cancer Prev Res (Phila); 2010 Apr; 3(4):505-17. PubMed ID: 20354165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
